Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis

Authors

Lequan Min
Ting Niu
Zhengyu Yu (ORCID: https://orcid.org/0000-0002-8888-4570)
Lingfeng Li (ORCID: https://orcid.org/0000-0001-9872-002X)
Lihua Xie (ORCID: https://orcid.org/0000-0002-4573-8215)
Caixia Jing (ORCID: https://orcid.org/0000-0002-0317-5485)
Zhongwang Wang

Institutions

Sichuan University (CN)
Chengdu University of Technology (CN)
West China Hospital of Sichuan University (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-11-19
DOI: https://doi.org/10.3389/fimmu.2025.1608768
Citations: 1
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 1.05

Funders

National Natural Science Foundation of China
Sichuan University
Natural Science Foundation of Sichuan Province
National Key Research and Development Program of China
West China Hospital, Sichuan University
Key Research and Development Program of Sichuan Province

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis

Lequan Min, Ting Niu, Zhengyu Yu, Lingfeng Li et al.

Nov 19, 2025

1 citations

Frontiers in Immunology

CAR-T cell therapy research

1.05

article

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis

Lequan Min, Ting Niu, Zhengyu Yu, Lingfeng Li, Lihua Xie, Caixia Jing, Zhongwang Wang

November 19, 2025article en

1 citations

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

Sichuan University (CN), Chengdu University of Technology (CN), West China Hospital of Sichuan University (CN)

National Natural Science Foundation of China, Sichuan University, Natural Science Foundation of Sichuan Province, National Key Research and Development Program of China, West China Hospital, Sichuan University, Key Research and Development Program of Sichuan Province

Openalex Percentile: Top 16%

CAR-T cell therapy research

1.05

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.